Description:
BMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection. It is a prodrug for BMS-626529, which binds to the viral envelope glycoprotein gp120 and interferes with attachment of the virus to the cellular CD4 receptor.
- Molecular Weight: 583.49
- Molecular Formula: C25H26N7O8P
Purity: >98%
Canonical SMILES:
CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC
InChI:
InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)
InChIKey: SWMDAPWAQQTBOG-UHFFFAOYSA-N
- Boiling Point: 904.1±75.0 °C at 760 mmHg
- Solubility: In Vitro: DMSO : ≥ 100 mg/mL(171.38 mM)H2O : 20 mg/mL(34.28 mM;Need ultrasonic)
- Appearance: White to off-white (Solid)
- Storage: Powder: -20°C: 3 years4°C: 2 yearsIn solvent: -80°C: 6 months-20°C: 1 month
Synonyms:
Fostemsavir; BMS-663068; BMS 663068; BMS663068
More details are to be found on supplier website